For research use only. Not for therapeutic Use.
N6-(2-Phenylethyl)adenosine (N6-Phenethyladenosine), an adenosine derivative, is a potent adenosine receptors (AR) agonist with Ki values of 11.8 nM, 30.1 nM, 0.63 nM for rat A1AR, human A1AR and hA3AR, respectively[1].
N6-(2-Phenylethyl)adenosine (N6-Phenethyladenosine) inhibits rA2AR (IC50=560 nM), hA2AR (IC50=2250 nM) in CHO cells[1].
Catalog Number | I020655 |
CAS Number | 20125-39-7 |
Synonyms | (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(2-phenylethylamino)purin-9-yl]oxolane-3,4-diol |
Molecular Formula | C18H21N5O4 |
Purity | ≥95% |
InChI | InChI=1S/C18H21N5O4/c24-8-12-14(25)15(26)18(27-12)23-10-22-13-16(20-9-21-17(13)23)19-7-6-11-4-2-1-3-5-11/h1-5,9-10,12,14-15,18,24-26H,6-8H2,(H,19,20,21)/t12-,14-,15-,18-/m1/s1 |
InChIKey | LGZYEDZSPHLISU-SCFUHWHPSA-N |
SMILES | C1=CC=C(C=C1)CCNC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O |
Reference | [1]. Tchilibon S, et al. Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands. Bioorg Med Chem. 2004 May 1;12(9):2021-34. |